| |
PROGRAM
22. ÅRSMØDE
DANSK SELSKAB FOR CANCERFORSKNING
Torsdag d. 7. Maj 2009 |
| |
| 08.00-08.55 |
Registrering, opsætning af posters og kaffe |
| 08.55-09.00 |
Welcome and practical information by the Chairman, Dr. Kirsten Grønbæk |
SESSION I:
Chairmen: |
Gastro-Intestinal Cancers
Irene Munk Petersen and Lennart Friis-Hansen |
| 09.00-09:15 |
Abs. No. 7: Colorectal mucosal prolapse in protease deficient mice:
Hald A, Rønø B, Holck S & Lund LR |
| 09.15-09.30 |
Abs. No. 49: Urokinase plasminogen activator receptor (uPAR) expression in
gastric carcinomas from high and low-risk countries:
Alpízar-Alpízar W, Nielsen BS, Sierra R, Illemann M, Ramírez JA, Arias A, Durán
S, Lund LR, Lærum OD |
| 09.30-09.45 |
Abs. No. 68: Regulation of NF-kB Signalling, Cell Survival and Oncogenesis by a
Ubiquitin-Binding Domain in Inhibitor of Apoptosis Proteins:
Gyrd-Hansen M, Darding M, Miasari, Santoro MM, Zender L, Xue W, Tenev T,
Lowe S, Silke J and Meier P |
| 09.45-10.00 |
Abs. No.34: High expression levels of miR-21 identified by in situ hybridization
in stage II colon cancer predict short disease-free survival:
Nielsen BS, Jørgensen S, Fog J, Christensen IJ, Christensen HS, Hansen U,
Brünner N, Baker A, Møller S, Nielsen HJ |
| 10.00-10.15 |
Abs. No 38: miR-449 inhibits growth of gastric cancer cells:
Futoma-Kazmierczak E, Jacobsen A, Krogh A, Lund A, Friis-Hansen L |
| 10.15-10.45 |
POSTERS & kaffe
|
SESSION II:
Chairmen: |
Molecular mechanisms
Niels Mailand and Peter Staller |
| 10.45-11.00 |
Abs. No. 60: Functional role of S100A4 in tumor stroma interaction:
Grum-Schwensen B, Lukanidin E, Ambartsumian N |
| 11.00-11.15 |
Abs. No. 42: Hypoxia-inducible factor promotes metabolic adaptation to hypoxia
by induction of Foxo3A:
Jensen KS, Breum S, Nielsen LG, Borup R, Samans B, Therkelsen I, Quistorff B,
Staller P |
| 11.15-11.30 |
Abs. No. 5: Construction and Use of Stable Recombinant Cancer Cell Libraries
Blaich S, Wittig R, Hudler M, Kacprzyk L, End C, Christiansen H, Riedel A,
Schmidt S, Sültmann H, Mollenhauer J |
| 11.30-11.45 |
Abs. No. 3: Proteomic screen for regulators of DNA damage-modified chromatin
Larsen DH, Poinsignon C, Payne MR, Danielsen JR, Mernard P, Bartek J,
Andersen JS, Lukas J |
| 11.45-12.00 |
Abs. No. 33: Characterization of the potential tumor suppressor PRDM11:
Fog CK, Jacobsen L, Jensen KT, Gredsted L, Lund AH |
| 12.00-12.30 |
Gårdejer Ingemann Petersen og hustrus Foundation:
Honorary prize and talk |
| 12.30-13.30 |
Lunch/Coffee
|
| 13.30-14.30 |
THE DANISH CANCER SOCIETY LECTURE:
Dr. Moshe Oren, Weizmann Institute of Science, Israel.
“p53 in Cancer”
Introduktion v. Dr. Anders H. Lund |
| 14.30-15.15 |
POSTERS & Coffee |
SESSION III: Chairmen:
|
Clinical and preclinical investigations
Jeppe Friborg and Helle Pappott |
| 15.15-15.30 |
Abs. No. 63: Towards individualized adjuvant chemotherapy in high risk breast
cancer patients:
Hertel P, Ejlertsen B, Jensen M, Nielsen KV, Balslev E, Rasmussen BB, Willemoe
GL, Knoop A, Mouridsen H, Brünner N |
| 15.30-15.45 |
Abs no. 17 Characterization of a novel nicotinamide dinucleotide synthesis
inhibitor TP201565 and its cellular resistance mechanisms:
Olesen UH, Thougaard A, Christensen MK, Björkling F, Tjørnelund J, Persson
M2, Petersen KD, Jensen PB, Nielsen SJ, Sehested M |
| 15.45-16.00 |
Abs. No 29. In vivo delivery of targeted gene therapeutics for small cell lung
cancer:
Gjetting T, Christensen CL, Andresen TL, Poulsen HS |
| 16.05-16.15 |
Abs. No 71: Immunological targeting of cancer traits:
thor Straten P and CCIT staff Centre for Cancer Immune Therapy (CCIT),
University Hospital Herlev, Denmark |
| 16.15-17.00 |
Refreshments and Posters |
| 17.00-17.15 |
Announcement of the 2009 Honorary member of the Danish Society for
Cancer Research |
| 17.15-17.20 |
Price for best talk |
| 17.20-17.25 |
Price for best poster |
| 17.25-18.00 |
PAUSE |
| 18.00-18.30 |
Aperitif |
| 18.30- |
Dinner |
|
